ASP-3325

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameASP-3325
Drug Alias NameASP-3325
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-dependent phosphate transport protein 2B inhibitors
TargetsSodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsHyperphosphatemiaRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsHyperphosphatemiaRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A